tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

AKBA Stock Latest News

Akebia Therapeutics Expands Vafseo Market at Healthcare Conference
Company AnnouncementsAkebia Therapeutics Expands Vafseo Market at Healthcare Conference
5d ago
8K
AKBA
Akebia announces ‘multiple positive business updates’
PremiumThe Fly
Akebia announces ‘multiple positive business updates’
5d ago
AKBA
Akebia: U.S. Renal Care enrolls first patient in its VOICE collaborative trial
PremiumThe Fly
Akebia: U.S. Renal Care enrolls first patient in its VOICE collaborative trial
2M ago
AKBA
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
ACAD
AKBA
Akebia Therapeutics Prepares for Vafseo Launch
PremiumCompany Announcements
Akebia Therapeutics Prepares for Vafseo Launch
2M ago
AKBA
Akebia reports Q3 EPS (10c), consensus (6c)
PremiumThe FlyAkebia reports Q3 EPS (10c), consensus (6c)
2M ago
AKBA
AKBA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
AKBA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
AKBA
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
AKBA
ALLK
GE Aerospace, GM report quarterly earnings beats: Morning Buzz
PremiumThe Fly
GE Aerospace, GM report quarterly earnings beats: Morning Buzz
3M ago
GE
GM
Akebia Therapeutics Secures Supply Agreement for Vafseo
PremiumCompany Announcements
Akebia Therapeutics Secures Supply Agreement for Vafseo
3M ago
8K
AKBA
Akebia signs commercial supply contract with dialysis organization
PremiumThe Fly
Akebia signs commercial supply contract with dialysis organization
3M ago
AKBA
Akebia: CMS grants TDAPA reimbursement for Vafseo starting January 1, 2025
PremiumThe Fly
Akebia: CMS grants TDAPA reimbursement for Vafseo starting January 1, 2025
3M ago
AKBA
Akebia, U.S. Renal Care sign commercial supply contract
PremiumThe FlyAkebia, U.S. Renal Care sign commercial supply contract
3M ago
AKBA
Akebia and U.S. Renal Care initiate trial of Vafseo for patients on dialysis
Premium
The Fly
Akebia and U.S. Renal Care initiate trial of Vafseo for patients on dialysis
5M ago
AKBA
Akebia price target raised to $7.50 from $6 at H.C. Wainwright
Premium
The Fly
Akebia price target raised to $7.50 from $6 at H.C. Wainwright
5M ago
AKBA
Akebia reports Q2 EPS (4c), consensus (5c)
PremiumThe Fly
Akebia reports Q2 EPS (4c), consensus (5c)
5M ago
AKBA
Is AKBA a Buy, Before Earnings?
PremiumPre-Earnings
Is AKBA a Buy, Before Earnings?
6M ago
AKBA
Akebia Therapeutics Ends Licensing Deal, Commits to Repayment Plan
PremiumCompany Announcements
Akebia Therapeutics Ends Licensing Deal, Commits to Repayment Plan
6M ago
8K
AKBA
Akebia, CSL Vifor enter termination agreement of the Vafseo license agreement
PremiumThe Fly
Akebia, CSL Vifor enter termination agreement of the Vafseo license agreement
6M ago
AKBA
Akebia Therapeutics Welcomes New CFO and Financial Strategist
PremiumCompany AnnouncementsAkebia Therapeutics Welcomes New CFO and Financial Strategist
7M ago
8K
AKBA
Akebia names Erik Ostrowski as CFO, Chief Business Officer
Premium
The Fly
Akebia names Erik Ostrowski as CFO, Chief Business Officer
7M ago
AKBA
Akebia expects cash to fund operations for at least next two years
Premium
The Fly
Akebia expects cash to fund operations for at least next two years
8M ago
AKBA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >